Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 16, 2026 07:30 ET | Source: Avicanna Inc.

Avicanna Introduces QUIX™ Rapid-Onset Medical Cannabis Portfolio

Initial Medical Cannabis SKUs, Including Rapid-Onset Capsules and Soft Chews, Planned for Q3 2026 Improving Patient Access with Accurately Dosed, Rapid-Onset and Non-Combustible Formats TORONTO,...
June 30, 2026 17:30 ET | Source: Avicanna Inc.

Avicanna Announces Promotion of Nick Hilborn CPA CA to Chief Financial Officer

TORONTO, June 30, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and...
June 12, 2026 17:30 ET | Source: Avicanna Inc.

Avicanna Announces Closing of Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
May 14, 2026 07:30 ET | Source: Avicanna Inc.

Avicanna Reports Q1 2026 Financial Statements

Record revenue and gross profits driven by Canadian commercial growth and proprietary product expansionContinued advancement of pharmaceutical pipeline, medical affairs initiatives and international...
May 08, 2026 07:30 ET | Source: Avicanna Inc.

Avicanna Announces Results of Annual General and Special Meeting

TORONTO, May 08, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and...
May 01, 2026 20:46 ET | Source: Avicanna Inc.

Avicanna Announces Change in Board of Directors

TORONTO, May 01, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and...
April 28, 2026 07:28 ET | Source: Avicanna Inc.

Avicanna Welcomes Initial U.S. Rescheduling of Medical Cannabis & Provides Scientific Update

Rescheduling aligns with Avicanna’s established pharmaceutical and medical cannabis strategyRescheduling further supports advancement of R&D, clinical development, and medical affairs initiatives ...
April 21, 2026 07:30 ET | Source: Avicanna Inc.

Annual General and Special Meeting of Shareholders to be held May 7, 2026

TORONTO, April 21, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and...
April 20, 2026 09:00 ET | Source: Avicanna Inc.

Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics

An established forum for evidence-based clinical discussion, interdisciplinary dialogue, and patient considerationsEvent is expanded to two days, live and virtual on June 11-12, 2026, at the MaRS...
April 06, 2026 17:30 ET | Source: Avicanna Inc.

Avicanna Announces Changes to its Board of Directors

TORONTO, April 06, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing...